Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials
Authors
Keywords
Schizophrenia, Major Depressive Disorder, Risperidone, Major Depressive Disorder, Aripiprazole
Journal
CNS DRUGS
Volume 30, Issue 11, Pages 1043-1054
Publisher
Springer Nature
Online
2016-08-22
DOI
10.1007/s40263-016-0382-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
- (2016) Suresh Durgam et al. AMERICAN JOURNAL OF PSYCHIATRY
- Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial
- (2016) G. Németh et al. EUROPEAN PSYCHIATRY
- Cariprazine in the treatment of schizophrenia
- (2016) Suresh Durgam et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
- (2016) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Effect of Cariprazine on Hostility Associated With Schizophrenia
- (2016) Leslie Citrome et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials
- (2015) Eduard Vieta et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
- (2015) Gary S. Sachs et al. JOURNAL OF AFFECTIVE DISORDERS
- Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) Suresh Durgam et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia
- (2015) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO
- (2015) Ragy R. Girgis et al. SCHIZOPHRENIA RESEARCH
- The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial
- (2014) Suresh Durgam et al. BIPOLAR DISORDERS
- Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder
- (2014) Joseph R. Calabrese et al. JOURNAL OF CLINICAL PSYCHIATRY
- Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis
- (2014) Ichiro Kusumi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania
- (2014) A. Yildiz et al. PSYCHOLOGICAL MEDICINE
- An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
- (2014) Suresh Durgam et al. SCHIZOPHRENIA RESEARCH
- Assessment and management of bipolar disorder: summary of updated NICE guidance
- (2014) T. Kendall et al. BMJ-British Medical Journal
- Management of psychosis and schizophrenia in adults: summary of updated NICE guidance
- (2014) E. Kuipers et al. BMJ-British Medical Journal
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis
- (2011) Jürgen De Fruyt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
- (2011) Romina Mizrahi et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials
- (2010) Christoph U Correll et al. BIPOLAR DISORDERS
- Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia
- (2010) Magdalena Nord et al. CNS Neuroscience & Therapeutics
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
- (2010) Ayşegül Yildiz et al. NEUROPSYCHOPHARMACOLOGY
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- Introduction to Meta-Analysis by Michael Borenstein, Larry V. Hedges, Julian P.T. Higgins, Hannah R. Rothstein
- (2009) Andreas Rosenblad INTERNATIONAL STATISTICAL REVIEW
- A re-evaluation of random-effects meta-analysis
- (2008) Julian P. T. Higgins et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started